State University of New York (SUNY) NEXT Clinical Site
纽约州立大学 (SUNY) NEXT 临床中心
基本信息
- 批准号:10593616
- 负责人:
- 金额:$ 31.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdultCatchment AreaChildChildhoodClinicClinicalClinical DataClinical ResearchClinical TrialsClinical Trials DesignClinical Trials NetworkComb animal structureCommunitiesCommunity OutreachConduct Clinical TrialsCountyData Coordinating CenterDevelopmentDiseaseEthicsEyeFacultyFundingGeographyGoalsGrantGrowthHealthHealth care facilityHospitalsIndustryInfrastructureInpatientsInstitutesInstitutional Review BoardsLeadershipLocal GovernmentMedicalMentorsModelingMorbidity - disease rateNational Institute of Neurological Disorders and StrokeNeurologicNeurologyNeurosciencesNew YorkParticipantPatient RecruitmentsPatientsPediatric HospitalsPerformancePopulationPopulation HeterogeneityPositioning AttributePrivatizationProtocols documentationPublic HealthPublicationsResearchResearch InfrastructureResearch PersonnelResourcesReview CommitteeRuralSiteSpecialistSpeedState GovernmentStructureTelemedicineTestingTimeTimeLineTrainingTranslational ResearchTranslationsUnderrepresented MinorityUnderserved PopulationUnited StatesUniversitiesWagesWorkbasecareerclinical investigationclinical research sitecommunity organizationscommunity partnershipcost effectivedata qualitydata sharingeffective therapyelectronic dataethnic diversityexperiencegeographic populationimprovedinnovationmeetingsmemberminority investigatormortalitynervous system disorderorganizational structureoutpatient facilitypatient advocacy grouppatient populationphase III trialracial and ethnicrecruitresponseretention raterural Americansrural healthcarerural patientssuccess
项目摘要
This application from the State University of New York (SUNY) responds to the NINDS RFA to participate as a Clinical Site in the Network for Excellence in Neuroscience Clinical Trials (NEXT). We have brought together the 4 SUNY Academic Health Centers (AHCs), their local, diverse communities, and their liaisons with hospital (including 4 children's hospitals) and clinic networks, large referral bases and patient volumes, and industry. This will insure a robust and accessible infrastructure to facilitate rapid developmental and implementation of protocols for adults and children to be recruited into neurological clinical trials throughout NY state. By combing 4 SUNY campuses into one application, we have created a highly innovative and considerable network of patients with extremely diverse ethnic and racial backgrounds combined with vast breadth and depth of faculty (over 100) disease subspecialization and expertise. Approximately 42% of the state's population lives within the counties/boroughs serves by this SUNY NEXT application. The SUNY NEXT is therefore in a position to shift performance models and improve public health on a faster timeline because of the size of the referral and catchment area and generalizability of the diverse patients seen. Momentum for highly successful SUNY cross-campus projects has increased dramatically in the past 8 years with key leadership forming and supporting the formation of SUNY Research Excellence in Academic Health (REACH) via institutional hard dollars and grants. This SUNY NEXT proposal will further enhance infrastructure and expand our multi-campus Clinical Trials Network that currently includes a U10 SUNY NEXT, U10 NETT Hub, U10 StrokeNET sites, U24 SIREN SubHub, and now a CTSA. Our experience includes over neurology 100 trials in the past 8+ years. We have built this network and continue to refine it to provide a comprehensive array of disease-specific expertise (adults and pediatric neurologic specialists/subspecialists), clinical trial expertise and experience including trial coordinators, clinical/ translational research infrastructure, institutional commitment, and ongoing/expanding community-based input and research. Our network can coordinate a large, geographically diverse cadre of disease-based investigators to implement studies efficiently in response to disease-specific opportunities (MTAs and cIRB use already in place), supported by SUNY NEXT currently in the top 1/3 (8th of 25) of NEXT sites for recruitment and retention with outstanding data quality. We also have a group of early stage investigators (ESIs), including under-represented minority investigators, who we will train and mentor in trials (including SUNY-wide video subspecialty telementoring) and who will compete for a yearly slot that protects time with funded salary support. We will explore, given our expertise and connectivity in telemedicine, the feasibility of performing trials to more remote, smaller sites affiliated with SUNY NEXT to gain even greater representation of rural Americans into trials. Our success will shift paradigms for collaborative structuring of trials and ultimately improve public health.
纽约州立大学(SUNY)的这份申请是为了响应NINDS RFA作为神经科学临床试验卓越网络(NEXT)的一个临床站点。我们汇集了4个纽约州立大学学术健康中心(AHC),他们的当地不同社区,以及他们与医院(包括4家儿童医院)和诊所网络、大型转诊基地和患者数量以及行业的联系。这将确保一个强大和可访问的基础设施,以促进快速开发和实施成人和儿童方案,以便在整个纽约州纳入神经学临床试验。通过将4个纽约州立大学校区合并为一个应用程序,我们创建了一个高度创新的相当大的患者网络,这些患者具有极其不同的民族和种族背景,并拥有广泛的教师广度和深度(超过100人)的疾病亚专科和专业知识。该州约42%的人口生活在这项纽约州立大学下一项申请所服务的县/区内。因此,纽约州立大学NeXT能够以更快的时间表转变绩效模式和改善公共卫生,因为转诊和收集区域的大小以及所看到的不同患者的普遍性。在过去的8年里,纽约州立大学非常成功的跨校园项目的势头急剧增强,主要领导层通过机构硬通货和赠款形成并支持了纽约州立大学学术健康卓越研究(REACH)的形成。这项纽约州立大学NEXT计划将进一步加强基础设施,并扩大我们的多园区临床试验网络,该网络目前包括U10 SUNY NEXT、U10 NETT中枢、U10 StrokeNET站点、U24警报子枢纽,现在还包括CTSA。我们的经验包括在过去8年多的时间里进行了100多项神经学试验。我们已经建立了这个网络,并继续完善它,以提供全面的疾病特定专业知识(成人和儿童神经学专家/小组专家)、临床试验专业知识和经验,包括试验协调员、临床/转化性研究基础设施、机构承诺以及持续/不断扩大的基于社区的投入和研究。我们的网络可以协调大量不同地域的疾病研究人员队伍,以有效地实施研究,以应对特定疾病的机会(MTA和CIRB的使用已经到位),并得到纽约州立大学NeXT的支持,目前在NEXT招聘和保留网站中排名前三分之一(25个网站中的第8个),数据质量出色。我们还有一组早期调查人员(ESIS),包括代表性不足的少数族裔调查人员,他们将在审判中进行培训和指导(包括全纽约大学的视频专业远程监控),他们将竞争年度职位,通过提供资金的工资支持来保护时间。鉴于我们在远程医疗方面的专业知识和连通性,我们将探索在更偏远、更小的附属于纽约州立大学的地点进行试验的可行性,以便在试验中获得更多美国农村人的代表。我们的成功将改变试验协作结构的模式,并最终改善公共卫生。
项目成果
期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Comparison of short-term outcomes of thrombolysis for in-hospital stroke and out-of-hospital stroke in United States.
- DOI:10.1161/strokeaha.113.000945
- 发表时间:2013-07
- 期刊:
- 影响因子:8.3
- 作者:Moradiya Y;Levine SR
- 通讯作者:Levine SR
Review, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria: Part 1: rapidly improving stroke symptoms.
- DOI:10.1161/strokeaha.113.000878
- 发表时间:2013-09
- 期刊:
- 影响因子:8.3
- 作者:Re-examining Acute Eligibility for Thrombolysis (TREAT) Task Force:;Levine SR;Khatri P;Broderick JP;Grotta JC;Kasner SE;Kim D;Meyer BC;Panagos P;Romano J;Scott P;NINDS rt-PA Stroke Trial Investigators
- 通讯作者:NINDS rt-PA Stroke Trial Investigators
The A's and B's of the ABC's of stroke mechanisms and recurrence in pediatric ischemic stroke.
小儿缺血性中风的中风机制和复发 ABC 的 A 和 B。
- DOI:10.1212/wnl.0b013e3182752ecd
- 发表时间:2012
- 期刊:
- 影响因子:9.9
- 作者:Levine,StevenR;Ichord,RebeccaN
- 通讯作者:Ichord,RebeccaN
Smoking and Mortality in Stroke Survivors: Can We Eliminate the Paradox?
- DOI:10.1016/j.jstrokecerebrovasdis.2013.10.026
- 发表时间:2014-07-01
- 期刊:
- 影响因子:2.5
- 作者:Levine, Deborah A.;Walter, James M.;Mulhorn, Kristine A.
- 通讯作者:Mulhorn, Kristine A.
The "almost magical" mobile stroke unit revolution.
“近乎神奇”的移动卒中装置革命。
- DOI:10.1212/wnl.0b013e318258f845
- 发表时间:2012
- 期刊:
- 影响因子:9.9
- 作者:Balucani,Clotilde;Levine,StevenR
- 通讯作者:Levine,StevenR
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN Richard LEVINE其他文献
STEVEN Richard LEVINE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN Richard LEVINE', 18)}}的其他基金
State University of New York (SUNY) NEXT Clinical Site
纽约州立大学 (SUNY) NEXT 临床中心
- 批准号:
10163277 - 财政年份:2018
- 资助金额:
$ 31.59万 - 项目类别:
SUNY DOWNSTATE "R TRAIN": NEUROLOGY RESEARCH EDUCATION PROGRAM
纽约州立大学城下分校“R TRAIN”:神经学研究教育计划
- 批准号:
8704201 - 财政年份:2012
- 资助金额:
$ 31.59万 - 项目类别:
State University of New York (SUNY) Downstate NETT Clinical Site Hub
纽约州立大学 (SUNY) 州下 NTT 临床站点中心
- 批准号:
8700552 - 财政年份:2012
- 资助金额:
$ 31.59万 - 项目类别:
State University of New York (SUNY) Downstate NETT Clinical Site Hub
纽约州立大学 (SUNY) 州下 NTT 临床站点中心
- 批准号:
8527868 - 财政年份:2012
- 资助金额:
$ 31.59万 - 项目类别:
SUNY DOWNSTATE "R TRAIN": NEUROLOGY RESEARCH EDUCATION PROGRAM
纽约州立大学城下分校“R TRAIN”:神经学研究教育计划
- 批准号:
8460037 - 财政年份:2012
- 资助金额:
$ 31.59万 - 项目类别:
State University of New York (SUNY) Downstate NETT Clinical Site Hub
纽约州立大学 (SUNY) 州下 NTT 临床站点中心
- 批准号:
8856677 - 财政年份:2012
- 资助金额:
$ 31.59万 - 项目类别:
SUNY DOWNSTATE "R TRAIN": NEUROLOGY RESEARCH EDUCATION PROGRAM
纽约州立大学城下分校“R TRAIN”:神经学研究教育计划
- 批准号:
9093866 - 财政年份:2012
- 资助金额:
$ 31.59万 - 项目类别:
SUNY DOWNSTATE "R TRAIN": NEUROLOGY RESEARCH EDUCATION PROGRAM
纽约州立大学城下分校“R TRAIN”:神经学研究教育计划
- 批准号:
8331848 - 财政年份:2012
- 资助金额:
$ 31.59万 - 项目类别:
State University of New York (SUNY) Downstate NETT Clinical Site Hub
纽约州立大学 (SUNY) 州下 NTT 临床站点中心
- 批准号:
8401735 - 财政年份:2012
- 资助金额:
$ 31.59万 - 项目类别:
SUNY DOWNSTATE "R TRAIN": NEUROLOGY RESEARCH EDUCATION PROGRAM
纽约州立大学城下分校“R TRAIN”:神经学研究教育计划
- 批准号:
8810273 - 财政年份:2012
- 资助金额:
$ 31.59万 - 项目类别:
相似海外基金
PhD Quantifying antibiotic resistance and antibiotic resistance selective chemicals in the River Almond Catchment Area - a baseline for risk assessmen
博士量化杏仁河集水区的抗生素耐药性和抗生素耐药性选择性化学品 - 风险评估的基线
- 批准号:
2891762 - 财政年份:2023
- 资助金额:
$ 31.59万 - 项目类别:
Studentship
The use of woody wetlands as a secondary wastewater treatment stage for small works in the Severn Trent catchment area
使用木质湿地作为塞文特伦特流域小型工程的二级废水处理阶段
- 批准号:
2748024 - 财政年份:2022
- 资助金额:
$ 31.59万 - 项目类别:
Studentship
Quantifying antibiotic resistance and antibiotic resistance selective chemicals in the River Almond Catchment Area - a baseline for risk assessment an
量化杏仁河集水区的抗生素耐药性和抗生素耐药性选择性化学品 - 风险评估的基线
- 批准号:
2727920 - 财政年份:2021
- 资助金额:
$ 31.59万 - 项目类别:
Studentship
Proposing index method of three dimensional water catchment area and peak discharge estimating method for debris flow scale prediction
提出三维集水面积指数法和泥石流规模预测峰值流量估算方法
- 批准号:
20K04706 - 财政年份:2020
- 资助金额:
$ 31.59万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Matter budget of microplastics in limnic ecosystems: sources, flow paths and sinks of microplastic particles in the model catchment area of Lake Tollense, Mecklenburg Western-Pomerania
湖泊生态系统中微塑料的物质收支:梅克伦堡西波美拉尼亚托伦斯湖模型集水区微塑料颗粒的来源、流动路径和汇
- 批准号:
411261467 - 财政年份:2018
- 资助金额:
$ 31.59万 - 项目类别:
Research Grants
Environmental direct payment and insurance using water quality index for catchment area of a domestic water reservoir
生活水库流域环境直接支付及水质指数保险
- 批准号:
16K15007 - 财政年份:2016
- 资助金额:
$ 31.59万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Adsorption of trace uranium on iron oxides: reconstruction of water chemistry from ancient lakes in Baikal catchment area.
铁氧化物上痕量铀的吸附:贝加尔湖流域古湖泊水化学的重建。
- 批准号:
15K21019 - 财政年份:2015
- 资助金额:
$ 31.59万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
A study on the wide-area administration of compulsory education by municipal merger and expanded catchment area
市级合并扩区的义务教育广域管理研究
- 批准号:
15K21597 - 财政年份:2015
- 资助金额:
$ 31.59万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
The impact of precipitation intensity and vegetation in the catchment area on autochthonous and allochthonous carbon transfer in stream biofilm food webs
流域降水强度和植被对河流生物膜食物网中本地和异地碳转移的影响
- 批准号:
233302479 - 财政年份:2013
- 资助金额:
$ 31.59万 - 项目类别:
Research Grants
Investigating quality of life, social support, stress and coping mechanisms and suicide in Posttraumatic Stress Disorder (PTSD) populations recruited from a longitudinal Epidemiological Catchment Area (ECA) study
调查从纵向流行病学聚集区 (ECA) 研究中招募的创伤后应激障碍 (PTSD) 人群的生活质量、社会支持、压力和应对机制以及自杀
- 批准号:
264870 - 财政年份:2012
- 资助金额:
$ 31.59万 - 项目类别:
Miscellaneous Programs